Top

Published in:

Open Access 01-03-2011

Optimal Use of Vitamin D When Treating Osteoporosis

Authors: Joop P. W. van den Bergh, Sandrine P. G. Bours, Tineke A. C. M. van Geel, Piet P. Geusens

Published in: Current Osteoporosis Reports | Issue 1/2011

Abstract

Inadequate serum 25-hydroxyvitamin D (25[OH]D) concentrations are associated with muscle weakness, decreased physical performance, and increased propensity in falls and fractures. This paper discusses several aspects with regard to vitamin D status and supplementation when treating patients with osteoporosis in relation to risks and prevention of falls and fractures. Based on evidence from literature, adequate supplementation with at least 700 IU of vitamin D, preferably cholecalciferol, is required for improving physical function and prevention of falls and fractures. Additional calcium supplementation may be considered when dietary calcium intake is below 700 mg/day. For optimal bone mineral density response in patients treated with antiresorptive or anabolic therapy, adequate vitamin D and calcium supplementation is also necessary. Monitoring of 25(OH)D levels during follow-up and adjustment of vitamin D supplementation should be considered to reach and maintain adequate serum 25(OH)D levels of at least 50 nmol/L, preferably greater than 75 nmol/L in all patients.

Osteoporosis prevention, diagnosis, and therapy. JAMA 2001, 285(6):785-795.

Bauer DC, Sklarin PM, Stone KL, Black DM, Nevitt MC, Ensrud KE, Arnaud CD, Genant HK, Garnero P, Delmas PD et al: Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures. J Bone Miner Res 1999, 14(8):1404–1410.CrossRefPubMed

Nguyen ND, Pongchaiyakul C, Center JR, Eisman JA, Nguyen TV: Identification of high-risk individuals for hip fracture: a 14-year prospective study. J Bone Miner Res 2005, 20(11):1921–1928.CrossRefPubMed

Quesada JM, Coopmans W, Ruiz B, Aljama P, Jans I, Bouillon R: Influence of vitamin D on parathyroid function in the elderly. J Clin Endocrinol Metab 1992, 75(2):494–501.CrossRefPubMed

Lips P: Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001, 22(4):477–501.CrossRefPubMed

Snijder MB, van Schoor NM, Pluijm SM, van Dam RM, Visser M, Lips P: Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 2006, 91(8):2980–2985.CrossRefPubMed

Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J, Knol DL, Lips P: Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 2007, 92(6):2058–2065.CrossRefPubMed

van Schoor NM, Visser M, Pluijm SM, Kuchuk N, Smit JH, Lips P: Vitamin D deficiency as a risk factor for osteoporotic fractures. Bone 2008, 42(2):260–266.CrossRefPubMed

LaCroix AZ, Kotchen J, Anderson G, Brzyski R, Cauley JA, Cummings SR, Gass M, Johnson KC, Ko M, Larson J et al: Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women’s Health Initiative calcium-vitamin D randomized controlled trial. J Gerontol A Biol Sci Med Sci 2009, 64(5):559–567.PubMed

10.

Holick MF: Vitamin D deficiency. N Engl J Med 2007, 357(3):266–281.CrossRefPubMed

11.

Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ: Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997, 7(5):439–443.CrossRefPubMed

12.

Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT, Petruschke RA, Chen E, de Papp AE: Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005, 90(6):3215–3224.CrossRefPubMed

13.

• Kuchuk NO, Pluijm SM, van Schoor NM, Looman CW, Smit JH, Lips P: Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab 2009, 94(4):1244–1250. This study shows that bone health and physical performance in older persons are likely to improve when serum 25(OH)D is raised.CrossRefPubMed

14.

Carnevale V, Nieddu L, Romagnoli E, Battista C, Mascia ML, Chiodini I, Eller-Vainicher C, Frusciante V, Santini SA, La Porta M et al: Regulation of PTH secretion by 25-hydroxyvitamin D and ionized calcium depends on vitamin D status: a study in a large cohort of healthy subjects. Bone 2010, 47(3):626–630.CrossRefPubMed

15.

Arabi A, Baddoura R, El-Rassi R, El-Hajj Fuleihan G: Age but not gender modulates the relationship between PTH and vitamin D. Bone 2010, 47(2):408–412.CrossRefPubMed

16.

Fisher A, Goh S, Srikusalanukul W, Davis M: Elevated serum PTH is independently associated with poor outcomes in older patients with hip fracture and vitamin D inadequacy. Calcif Tissue Int 2009, 85(4):301–309.CrossRefPubMed

17.

Fisher AA, Southcott EK, Srikusalanukul W, Davis MW, Hickman PE, Potter JM, Smith PN: Relationships between myocardial injury, all-cause mortality, vitamin D, PTH, and biochemical bone turnover markers in older patients with hip fractures. Ann Clin Lab Sci 2007, 37(3):222–232.PubMed

18.

Chel V, Wijnhoven HA, Smit JH, Ooms M, Lips P: Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int 2008, 19(5):663–671.CrossRefPubMed

19.

Leidig-Bruckner G, Roth HJ, Bruckner T, Lorenz A, Raue F, Frank-Raue K: Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels-an observational study during clinical practice conditions. Osteoporos Int 2010.

20.

Aloia J, Bojadzievski T, Yusupov E, Shahzad G, Pollack S, Mikhail M, Yeh J: The relative influence of calcium intake and vitamin D status on serum parathyroid hormone and bone turnover biomarkers in a double-blind, placebo-controlled parallel group, longitudinal factorial design. J Clin Endocrinol Metab 2010, 95(7):3216–3224.CrossRefPubMed

21.

Malabanan A, Veronikis IE, Holick MF: Redefining vitamin D insufficiency. Lancet 1998, 351(9105):805–806.CrossRefPubMed

22.

Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D, Nickelsen T: A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 2001, 86(3):1212–1221.CrossRefPubMed

23.

Bischoff HA, Borchers M, Gudat F, Duermueller U, Theiler R, Stahelin HB, Dick W: In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 2001, 33(1):19–24.CrossRefPubMed

24.

Bischoff-Ferrari HA, Borchers M, Gudat F, Durmuller U, Stahelin HB, Dick W: Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 2004, 19(2):265–269.CrossRefPubMed

25.

Janssen HC, Samson MM, Verhaar HJ: Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr 2002, 75(4):611–615.PubMed

26.

Dhesi JK, Bearne LM, Moniz C, Hurley MV, Jackson SH, Swift CG, Allain TJ: Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res 2002, 17(5):891–897.CrossRefPubMed

27.

Pfeifer M, Begerow B, Minne HW: Vitamin D and muscle function. Osteoporos Int 2002, 13(3):187–194.CrossRefPubMed

28.

Visser M, Deeg DJ, Lips P: Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003, 88(12):5766–5772.CrossRefPubMed

29.

Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, Karlson EW, Dawson-Hughes B: Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am J Clin Nutr 2004, 80(3):752–758.PubMed

30.

Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner-Pammer A, Dobnig H: Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int 2009, 20(2):315–322.CrossRefPubMed

31.

Bischoff HA, Stahelin HB, Dick W, Akos R, Knecht M, Salis C, Nebiker M, Theiler R, Pfeifer M, Begerow B et al: Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003, 18(2):343–351.CrossRefPubMed

32.

Lips P, Binkley N, Pfeifer M, Recker R, Samanta S, Cohn DA, Chandler J, Rosenberg E, Papanicolaou DA: Once-weekly dose of 8400 IU vitamin D(3) compared with placebo: effects on neuromuscular function and tolerability in older adults with vitamin D insufficiency. Am J Clin Nutr 2010, 91(4):985–991.CrossRefPubMed

33.

Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB: Effect of Vitamin D on falls: a meta-analysis. JAMA 2004, 291(16):1999−2006.CrossRefPubMed

34.

Richy F, Dukas L, Schacht E: Differential effects of D-hormone analogs and native vitamin D on the risk of falls: a comparative meta-analysis. Calcif Tissue Int 2008, 82(2):102–107.CrossRefPubMed

35.

O’Donnell S, Moher D, Thomas K, Hanley DA, Cranney A: Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls. J Bone Miner Metab 2008, 26(6):531–542.CrossRefPubMed

36.

Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J: Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009, 339:b3692.CrossRefPubMed

37.

Gillespie LD, Robertson MC, Gillespie WJ, Lamb SE, Gates S, Cumming RG, Rowe BH: Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2009(2):CD007146.

38.

Cameron ID, Murray GR, Gillespie LD, Robertson MC, Hill KD, Cumming RG, Kerse N: Interventions for preventing falls in older people in nursing care facilities and hospitals. Cochrane Database Syst Rev 2010(1):CD005465.

39.

Kalyani RR, Stein B, Valiyil R, Manno R, Maynard JW, Crews DC: Vitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysis. J Am Geriatr Soc 2010, 58(7):1299–1310.CrossRefPubMed

40.

Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B: Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005, 293(18):2257–2264.CrossRefPubMed

41.

Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren D, Haentjens P: Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 2007, 92(4):1415–1423.CrossRefPubMed

42.

Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A: Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007, 370(9588):657–666.CrossRefPubMed

43.

•• Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, Thoma A, Kiel DP, Henschkowski J: Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009, 169(6):551–561. This is an important recent meta-analysis with regard to fracture prevemtion with vitamin D and the dose dependency.CrossRefPubMed

44.

•• Avenell A, Gillespie WJ, Gillespie LD, O’Connell D: Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2009(2):CD000227. In this Cochrane review the effect of vitamin D on prevention of fractures is extensively analyzed.

45.

Bergman GJ, Fan T, McFetridge JT, Sen SS: Efficacy of vitamin D3 supplementation in preventing fractures in elderly women: a meta-analysis. Curr Med Res Opin 2010, 26(5):1193–1201.CrossRefPubMed

46.

•• Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 2010, 340:b5463. This is another important recently published pooled analysis with regard to fracture prevention with vitamin D.

47.

Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ: Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992, 327(23):1637–1642.CrossRefPubMed

48.

Chapuy MC, Pamphile R, Paris E, Kempf C, Schlichting M, Arnaud S, Garnero P, Meunier PJ: Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002, 13(3):257–264.CrossRefPubMed

49.

• Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC: Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010, 303(18):1815–1822. This study demonstrates that a single annual 500,000 IU oral dose of cholecalciferol increased risk of falls and fractures, with the greatest increase occurring during the first 3 months after dosing.CrossRefPubMed

50.

Smith H, Anderson F, Raphael H, Maslin P, Crozier S, Cooper C: Effect of annual intramuscular vitamin D on fracture risk in elderly men and women—a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) 2007, 46(12):1852–1857.CrossRef

51.

Ishijima M, Sakamoto Y, Yamanaka M, Tokita A, Kitahara K, Kaneko H, Kurosawa H: Minimum Required Vitamin D Level for Optimal Increase in Bone Mineral Density with Alendronate Treatment in Osteoporotic Women. Calcif Tissue Int 2009.

52.

Antoniucci DM, Vittinghoff E, Palermo L, Black DM, Sellmeyer DE: Vitamin D insufficiency does not affect response of bone mineral density to alendronate. Osteoporos Int 2009, 20(7):1259–1266.CrossRefPubMed

53.

Antoniucci DM, Vittinghoff E, Blackwell T, Black DM, Sellmeyer DE: Vitamin D insufficiency does not affect bone mineral density response to raloxifene. J Clin Endocrinol Metab 2005, 90(8):4566–4572.CrossRefPubMed

54.

Heaney RP: Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004, 80(6 Suppl):1706S–1709S.PubMed

55.

Theiler R, Stahelin HB, Kranzlin M, Somorjai G, Singer-Lindpaintner L, Conzelmann M, Geusens P, Bischoff HA: Influence of physical mobility and season on 25-hydroxyvitamin D-parathyroid hormone interaction and bone remodelling in the elderly. Eur J Endocrinol 2000, 143(5):673–679.CrossRefPubMed

56.

Trivedi DP, Doll R, Khaw KT: Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003, 326(7387):469.CrossRefPubMed

57.

Yates AA, Schlicker SA, Suitor CW: Dietary Reference Intakes: the new basis for recommendations for calcium and related nutrients, B vitamins, and choline. J Am Diet Assoc 1998, 98(6):699–706.CrossRefPubMed

58.

• Bischoff-Ferrari HA, Kiel DP, Dawson-Hughes B, Orav JE, Li R, Spiegelman D, Dietrich T, Willett WC: Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res 2009, 24(5):935–942. In this study, 25(OH)D status is more important than increasing dietary calcium intake for improving hip BMD.CrossRefPubMed

59.

Bischoff-Ferrari HA, Dawson-Hughes B, Baron JA, Burckhardt P, Li R, Spiegelman D, Specker B, Orav JE, Wong JB, Staehelin HB et al: Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr 2007, 86(6):1780–1790.PubMed

60.

Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR: Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010, 341:c3691.CrossRefPubMed

Title: Optimal Use of Vitamin D When Treating Osteoporosis
Authors: Joop P. W. van den Bergh
Sandrine P. G. Bours
Tineke A. C. M. van Geel
Piet P. Geusens
Publication date: 01-03-2011
Publisher: Current Science Inc.
Published in: Current Osteoporosis Reports / Issue 1/2011
Print ISSN: 1544-1873
Electronic ISSN: 1544-2241
DOI: https://doi.org/10.1007/s11914-010-0041-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Optimal Use of Vitamin D When Treating Osteoporosis

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2011

Use of Strontium as a Treatment Method for Osteoporosis

Osteoporosis in Men: What has Changed?

Androgen Deprivation and Bone

Denosumab: What’s New?

Defining Zoledronate’s Duration of Action and Optimal Dosing Interval for an Effective Therapy

Oral Contraceptive Use and Bone